Breast cancer cell survival signal is affected by bergapten combined with an ultraviolet irradiation

[1]  S. Andò,et al.  Evidence that bergapten, independently of its photoactivation, enhances p53 gene expression and induces apoptosis in human breast cancer cells. , 2009, Current cancer drug targets.

[2]  S. Andò,et al.  Evidence that low doses of Taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF‐7 breast cancer cells , 2006, FEBS letters.

[3]  O. Braun-falco,et al.  The human peripheral lymphocyte—a model system for studying the combined effect of psoralen plus black light , 1977, Klinische Wochenschrift.

[4]  C. Arteaga.  Interference of the IGF system as a strategy to inhibit breast cancer growth , 2005, Breast Cancer Research and Treatment.

[5]  L. Sciacca,et al.  Type I insulin-like growth factor receptor function in breast cancer , 1998, Breast Cancer Research and Treatment.

[6]  M. Richard,et al.  La photochimiothérapie extracorporelle dans le traitement de pathologies du système lymphocytaire T , 2003 .

[7]  M. Richard,et al.  [Extracorporeal photochemotherapy for treatment of clonal T cell proliferations]. , 2003, Bulletin du cancer.

[8]  H. Senn,et al.  Insulin-Like Growth Factors and Breast Cancer , 2003, Oncology Research and Treatment.

[9]  L. Mayo,et al.  The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. , 2002, Trends in biochemical sciences.

[10]  R. Vollandt,et al.  Drug Monitoring of Orally Administered 8-Methoxypsoralen in Patients Treated with Extracorporeal Photopheresis , 1998, Skin Pharmacology and Physiology.

[11]  G. Plewig,et al.  Psoralen bath plus UV-A therapy. Possibilities and limitations. , 1997, Archives of dermatology.

[12]  F. Gasparro,et al.  Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. , 1996, The Journal of investigative dermatology.

[13]  W. Morison,et al.  Photochemotherapy beyond psoriasis. , 1994, Journal of the American Academy of Dermatology.

[14]  John Calvin Reed,et al.  Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.

[15]  C. Kao,et al.  Comparison of the effect of 8-methoxypsoralen (8-MOP) plus UVA (PUVA) on human melanocytes in vitiligo vulgaris and in vitro. , 1992, The Journal of investigative dermatology.

[16]  D. Marks,et al.  Mechanisms of photochemotherapy-induced apoptotic cell death in lymphoid cells. , 1991, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[17]  F. Gasparro,et al.  Formation and removal of 8-MOP-DNA photoadducts in keratinocytes: effects of calcium concentration and retinoids. , 1990, The Journal of investigative dermatology.

[18]  J. Parrish,et al.  Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. , 1974, The New England journal of medicine.

[19]  J. Delhanty,et al.  DNA synthesis in normal and xeroderma pigmentosum fibroblasts following treatment with 8-methoxypsoralen and long wave ultraviolet light. , 1972, Biochimica et biophysica acta.